CLARK IAN T 4
4 · Olema Pharmaceuticals, Inc. · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
Olema (OLMA) Director Ian T. Clark Receives Stock Award
What Happened Ian T. Clark, a director of Olema Pharmaceuticals (OLMA), was granted a derivative award covering 29,500 shares on June 18, 2026. The grant is reported on the Form 4 as an acquisition (code A) at $0.00 (i.e., recorded as a stock option/award rather than an open‑market purchase or sale).
Key Details
- Transaction date: 2026-06-18; Report filed: 2026-06-23 (filing was late by one business day).
- Transaction type: Grant/Award (derivative) for 29,500 shares, reported price $0.00.
- Shares owned after transaction: Not disclosed in the filing excerpt.
- Vesting (from footnote): Vesting in 12 equal monthly installments beginning June 18, 2026; any unvested portion vests in full on the issuer’s next annual meeting if not otherwise fully vested, subject to continuous service.
- No 10b5-1 plan, tax withholding, or immediate sale reported in this filing.
Context This was a grant of an equity award (derivative/option) rather than a purchase or sale of stock. Such awards typically serve as compensation and vest over time; they do not by themselves signal an immediate buy or sell by the insider. The late filing is procedural and should be noted but does not, by itself, imply any change in company fundamentals.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-06-18+29,500→ 29,500 totalExercise: $9.51Exp: 2036-06-18→ Common Stock (29,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 18, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.